Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Odf4 Activators

Forskolin, a diterpene, exerts its effects by directly stimulating adenylyl cyclase, which catalyzes the conversion of ATP to cAMP, a secondary messenger that activates protein kinase A (PKA). Elevated PKA activity leads to enhanced phosphorylation of target proteins, effectively altering their function. Similarly, IBMX, a methylxanthine derivative, prevents the breakdown of cAMP by inhibiting phosphodiesterases, sustaining an environment conducive to PKA-mediated phosphorylation. The polyphenol compound epigallocatechin gallate and the stilbenoid resveratrol are capable of modulating numerous signaling pathways and affecting various proteins' activity and state of activation.

Ionomycin, a calcium ionophore, and A23187, a carboxylic acid, both serve to increase intracellular levels of calcium, a critical second messenger that activates a suite of calcium-dependent kinases, which then may phosphorylate proteins. Phorbol 12-myristate 13-acetate, a potent activator of protein kinase C (PKC), directly stimulates PKC which is involved in a wide range of cellular functions, including the regulation of protein activities through phosphorylation. Phosphodiesterase inhibitors like sildenafil maintain elevated levels of cAMP and cGMP, thus facilitating the activation of PKA or PKG, kinases that catalyze the transfer of phosphate groups to proteins. LY294002, a flavonoid derivative, acts by inhibiting phosphoinositide 3-kinases (PI3K), thereby affecting downstream signaling cascades, which can lead to modifications in protein activity. The small molecule U0126, known for its inhibitory effect on mitogen-activated protein kinase kinase (MEK), has the capacity to alter the phosphorylation patterns within cells, impacting protein function. Dibutyryl cAMP, a synthetic analog of cAMP, and staurosporine, an alkaloid that inhibits a broad spectrum of kinases, both result in phosphorylation changes that can activate proteins.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Increases intracellular calcium, activating calcium-dependent kinases that may phosphorylate proteins.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates PKC, which can phosphorylate proteins and alter their activity.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Inhibits phosphodiesterases, increasing cAMP levels and enhancing PKA activity, affecting protein phosphorylation.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Modulates various signaling pathways that could lead to the activation of proteins.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

Ionophore that raises intracellular calcium, affecting protein activity through calcium-sensitive pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, altering downstream signaling pathways that could lead to protein activation.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Inhibits MEK, potentially causing changes in protein phosphorylation and activation.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

A cAMP analog that activates PKA, leading to phosphorylation and activation of proteins.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Inhibits protein kinases, potentially causing shifts in protein activity.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Activates SIRT1, leading to deacetylation of proteins and potential changes in activity.